Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (6)
  • 2024 (3)
  • 2023 (9)
  • 2022 (9)
  • 2021 (14)
  • 2020 (1)

Subject

  • Drug Trafficking (250)
  • Synthetic drugs (195)
  • Seizures (Drugs/Property) (188)
  • Task Forces/Task Force Officers (170)
  • Major Law Enforcement Operation (139)
  • Guns/Weapons (106)
  • OCDETF/Task Force (87)
  • Overdose (73)
  • Arrests/Convictions - Major (69)
  • Prescription Drugs (68)
  • Fake Pills (66)
  • Gangs (51)
  • Outreach/Drug Prevention (50)
  • Pharmaceuticals/Pharmacists/Physicians (44)
  • Narcoterrorism (41)
  • Take Back Day (36)
  • Press Conferences (32)
  • Guilty Plea (31)
  • Public and Media Affairs - also see Congressional Affairs (26)
  • Money Laundering (24)
  • One Pill Can Kill (20)
  • Fentanyl Awareness (18)
  • Prevention/Education - DEA websites GSAD, JTT etc (15)
  • Congressional Affairs (12)
  • HIDTA (10)
  • International/Foreign Operations (10)
  • Red Ribbon (9)
  • Dark Web- Internet Trafficking (8)
  • Extraditions (7)
  • Fentanyl Free America (6)
  • Intergovernmental Affairs (6)
  • Asset Forfeiture (5)
  • Counterfeit Pills (5)
  • Campaigns (3)
  • Critical Incident (3)
  • Museum and Visitors Center (3)
  • Terrorism (3)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Cartel (1)
  • Other (1)
  • Diversion Division (44)

Drug Name

  • Opioids (21)
  • Oxycodone (12)
  • Synthetic Opioids (10)
  • Fentanyl (7)
  • Hydromorphone (4)
  • Benzodiazepines (3)
  • Steroids (3)
  • Methamphetamine (2)
  • Morphine (2)
  • Cocaine (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Methadone (1)

Field Division

  • New England (35)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • Houston (16)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • El Paso (8)
  • New Orleans (8)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Washington, DC (34)
  • Sede (10)
Clear All Results
44 Results - Showing 1 to 10
PRESS RELEASE

DEA Operation Meltdown Shuts Down Hundreds of Illegal Online Pharmacies

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Washington, DC – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
PRESS RELEASE

2025 National Health Care Fraud Takedown

ALEXANDRIA, Va. – Erik S. Siebert, U.S. Attorney for the Eastern District of Virginia, announced criminal charges against six defendants. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown . The charges are part of a strategically coordinated, nationwide law...
PRESS RELEASE

Physician Sentenced to 18 Years in Prison for Operating a Pill Mill from His Northwest D.C. Medical Practice

WASHINGTON -- Ndubuisi Joseph Okafor, M.D., 65, of Upper Marlboro, Maryland, was sentenced today in U.S. District Court to 18 years in prison for illegally distributing prescriptions for narcotics in exchange for cash from his Northwest Washington D.C. medical clinic. A jury found Okafor guilty on Mar. 21, 2025, of...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
PRESS RELEASE

DEA Safely Disposes 620,000 Pounds of Unused Medication on 28th National Prescription Drug Take Back Day

WASHINGTON D.C. – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Locally, the...
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster